Altered pattern of monocyte differentiation and monocyte-derived TGF-β1 in severe asthma

Chih-Hsing Hung1,2,3,4,5, Chin-Chou Wang6,7, Jau-Ling Suen3,5,8

  • 1Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

Scientific Reports
|January 19, 2018
PubMed

Insights

In asthma patients, circulating PM-2K+ macrophage-like cells are reduced, while fibrocytes increase. Monocyte-derived TGF-β1 also correlates with asthma severity and lung function decline.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Cell Biology

Background:

  • CD14+ monocytes are precursors to macrophages and fibrocytes, implicated in airway remodeling in asthma.
  • The PM-2K marker distinguishes these cells, but their circulating subsets and roles in asthma remain unclear.

Purpose of the Study:

  • To identify circulating PM-2K+ macrophage-like cell subsets in asthma.
  • To evaluate the relationship between these subsets, fibrocytes, and asthma severity, lung function, and control status.

Main Methods:

  • Multi-parametric flow cytometry was used to identify and distinguish circulating PM-2K+ macrophage-like cells and fibrocytes.
  • Analysis included comparisons between normal individuals and asthmatic subjects with varying lung function and severity.
  • The effect of transforming growth factor beta 1 (TGF-β1) on monocyte differentiation was investigated in vitro.

Main Results:

  • Asthmatic subjects had significantly lower levels of PM-2K+ macrophage-like cells, especially the CD14-PM-2K+ subset.
  • Reduced PM-2K+ macrophage-like cells and increased fibrocytes correlated with poorer lung function (FEV%/FVC% < 80%) and varying asthma severity.
  • Exogenous TGF-β1 inhibited PM-2K+ macrophage-like cell generation while promoting fibrocyte growth; monocyte-derived TGF-β1 correlated with asthma status.

Conclusions:

  • Aberrant monocyte differentiation into PM-2K+ macrophage-like cells and fibrocytes characterizes asthma.
  • Increased monocyte-derived TGF-β1 is associated with severe asthma, poor lung function, and impaired control.
  • These findings highlight potential diagnostic and therapeutic targets in asthma management.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
TGF - &#946; Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
Alterations in Respiration II01:30

Alterations in Respiration II

There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
1.9K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K